Agilon Health, Inc. (AGL)
115.66
+5.36
(+4.86%)
USD |
NYSE |
Nov 13, 16:00
115.65
-0.01
(-0.01%)
After-Hours: 19:59
Agilon Health Enterprise Value : 1.664B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.664B |
| November 12, 2026 | 1.574B |
| November 11, 2026 | 1.650B |
| November 10, 2026 | 1.628B |
| November 09, 2026 | 1.637B |
| November 06, 2026 | 1.626B |
| November 05, 2026 | 1.632B |
| November 04, 2026 | 1.338B |
| November 03, 2026 | 1.196B |
| November 02, 2026 | 1.177B |
| October 30, 2026 | 1.148B |
| October 29, 2026 | 1.165B |
| October 28, 2026 | 1.250B |
| October 27, 2026 | 1.244B |
| October 26, 2026 | 1.239B |
| October 23, 2026 | 1.228B |
| October 22, 2026 | 1.238B |
| October 21, 2026 | 1.250B |
| October 20, 2026 | 1.262B |
| October 19, 2026 | 1.214B |
| October 16, 2026 | 1.151B |
| October 15, 2026 | 1.207B |
| October 14, 2026 | 1.190B |
| October 13, 2026 | 1.164B |
| October 12, 2026 | 1.157B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.105B |
| October 08, 2026 | 1.145B |
| October 07, 2026 | 1.161B |
| October 06, 2026 | 1.122B |
| October 05, 2026 | 1.137B |
| October 02, 2026 | 1.135B |
| October 01, 2026 | 1.104B |
| September 30, 2026 | 1.058B |
| September 29, 2026 | 1.088B |
| September 28, 2026 | 1.111B |
| September 25, 2026 | 1.131B |
| September 24, 2026 | 1.049B |
| September 23, 2026 | 1.196B |
| September 22, 2026 | 1.234B |
| September 21, 2026 | 1.254B |
| September 18, 2026 | 1.273B |
| September 17, 2026 | 1.273B |
| September 16, 2026 | 1.281B |
| September 15, 2026 | 1.322B |
| September 14, 2026 | 1.327B |
| September 11, 2026 | 1.283B |
| September 10, 2026 | 1.330B |
| September 09, 2026 | 1.347B |
| September 08, 2026 | 1.310B |
| September 04, 2026 | 1.262B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 1.922B |
| Starling Oncology, Inc. | 422.80M |
| Nakamoto, Inc. | 237.18M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 153.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 34.91M |
| Revenue (Quarterly) | 1.519B |
| Total Expenses (Quarterly) | 1.485B |
| EPS Diluted (Quarterly) | 1.974 |
| Gross Profit Margin (Quarterly) | 6.00% |
| Profit Margin (Quarterly) | 2.30% |
| Earnings Yield | -5.69% |
| Normalized Earnings Yield | -3.721 |